Literature DB >> 16766534

Tumor suppressor p16INK4A regulates polycomb-mediated DNA hypermethylation in human mammary epithelial cells.

Paul A Reynolds1, Mahvash Sigaroudinia, Giuseppe Zardo, Matthew B Wilson, Geoffrey M Benton, Caroline J Miller, Chibo Hong, Jane Fridlyand, Joseph F Costello, Thea D Tlsty.   

Abstract

Alterations in DNA methylation are important in cancer, but the acquisition of these alterations is poorly understood. Using an unbiased global screen for CpG island methylation events, we have identified a non-random pattern of DNA hypermethylation acquired in p16-repressed cells. Interestingly, this pattern included loci located upstream of a number of homeobox genes. Upon removal of p16(INK4A) activity in primary human mammary epithelial cells, polycomb repressors, EZH2 and SUZ12, are up-regulated and recruited to HOXA9, a locus expressed during normal breast development and epigenetically silenced in breast cancer. We demonstrate that at this targeted locus, the up-regulation of polycomb repressors is accompanied by the recruitment of DNA methyltransferases and the hypermethylation of DNA, an endpoint, which we show to be dependent on SUZ12 expression. These results demonstrate a causal role of p16(INK4A) disruption in modulating DNA hypermethylation, and identify a dynamic and active process whereby epigenetic modulation of gene expression is activated as an early event in breast tumor progression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16766534     DOI: 10.1074/jbc.M604175200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  60 in total

1.  A key role for EZH2 in epigenetic silencing of HOX genes in mantle cell lymphoma.

Authors:  Meena Kanduri; Birgitta Sander; Stavroula Ntoufa; Nikos Papakonstantinou; Lesley-Ann Sutton; Kostas Stamatopoulos; Chandrasekhar Kanduri; Richard Rosenquist
Journal:  Epigenetics       Date:  2013-10-09       Impact factor: 4.528

2.  Sustained induction of epithelial to mesenchymal transition activates DNA methylation of genes silenced in basal-like breast cancers.

Authors:  Nancy Dumont; Matthew B Wilson; Yongping G Crawford; Paul A Reynolds; Mahvash Sigaroudinia; Thea D Tlsty
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-19       Impact factor: 11.205

3.  Homeobox Gene Deregulation: Impact on the Hallmarks of Cancer.

Authors:  Dhwani Haria; Honami Naora
Journal:  Cancer Hallm       Date:  2013-09-01

Review 4.  Epigenomics and breast cancer.

Authors:  Pang-Kuo Lo; Saraswati Sukumar
Journal:  Pharmacogenomics       Date:  2008-12       Impact factor: 2.533

5.  Polycomb (PcG) proteins, BMI1 and SUZ12, regulate arsenic-induced cell transformation.

Authors:  Hong-Gyum Kim; Dong Joon Kim; Shengqing Li; Kun Yeong Lee; Xiang Li; Ann M Bode; Zigang Dong
Journal:  J Biol Chem       Date:  2012-07-28       Impact factor: 5.157

6.  Human mammary cancer progression model recapitulates methylation events associated with breast premalignancy.

Authors:  Nancy Dumont; Yongping G Crawford; Mahvash Sigaroudinia; Shefali S Nagrani; Matthew B Wilson; Gertrude C Buehring; Gulisa Turashvili; Samuel Aparicio; Mona L Gauthier; Colleen A Fordyce; Kimberly M McDermott; Thea D Tlsty
Journal:  Breast Cancer Res       Date:  2009-12-08       Impact factor: 6.466

7.  Nucleoside drugs induce cellular differentiation by caspase-dependent degradation of stem cell factors.

Authors:  Tanja Musch; Yuva Oz; Frank Lyko; Achim Breiling
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

8.  Rare somatic cells from human breast tissue exhibit extensive lineage plasticity.

Authors:  Somdutta Roy; Philippe Gascard; Nancy Dumont; Jianxin Zhao; Deng Pan; Sarah Petrie; Marta Margeta; Thea D Tlsty
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-04       Impact factor: 11.205

9.  HOX proteins and leukemia.

Authors:  Kajal V Sitwala; Monisha N Dandekar; Jay L Hess
Journal:  Int J Clin Exp Pathol       Date:  2008-03-30

10.  Silencing of the Lats2 tumor suppressor overrides a p53-dependent oncogenic stress checkpoint and enables mutant H-Ras-driven cell transformation.

Authors:  Y Aylon; N Yabuta; H Besserglick; Y Buganim; V Rotter; H Nojima; M Oren
Journal:  Oncogene       Date:  2009-10-26       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.